Quarterly Outlook
Macro Outlook: The US rate cut cycle has begun
Peter Garnry
Chief Investment Strategist
Chief Investment Strategist
Summary: By sheer coincidence we launched our current bubble stocks basket on the 12 February 2021 which happened to be the exact day when the Ark Innovation ETF peaked on close prices. Since then our bubble stocks basket is down 55.2% in what has been a bloodbath among these speculative growth stocks as interest rates have charged higher on rising inflationary pressures. The plunge in bubble stocks has caused a dramatic cleanup of the basket as former bubble stocks are no longer meeting the criteria with 26 out 40 stocks leaving the basket.
Echo from the past
Our bubble stocks basket was a high-flying basket in the beginning of last year, but the gradually higher interest rates and inflation pressures driven by higher energy prices forced investors to rethink equity portfolios. As a result a rotation process was set in motion which led to bubble stocks (speculative growth stocks) to be shredded in masse while commodity and value related stocks were increased in portfolios. This rotation is very clear when you look at 1-year performance and year-to-date performance among our theme baskets.
We introduced our bubble basket on 8 January 2021 and updated our methodology during early February publishing a renewed basket on 12 February 2021 in which we warned of bubble stocks. In a striking coincidence the 12 February 2021 happened to be the day when the Ark Innovation ETF peaked on close prices. Since that day almost a year ago, our bubble stocks basket is down 55.2%, slightly more than the Ark Innovation ETF down 53.4%, basically behaving as we warned about in February 2021 that higher interest rates due to inflation pressures would severely pressure these stocks. In many ways the collapse in bubble stocks fell like an echo from the dot-com bubble days and the downward pressure may continue.
As the long-term chart also show, the bubble stocks basket is currently back to levels from September 2020, but still up significantly over a five-year period. However, the key risk remains higher interest rates as this group of stocks has a high equity duration, meaning that their terminal value is very sensitive to changes in the discount rate.
Significant changes to the bubble basket
The methodology behind the bubble stocks basket is not changing and thus we are still selecting the 40 largest stocks on market capitalization with the following characteristics:
Based on a current screening there are 26 stocks out of 40 stocks leaving the bubble stocks basket:
Many of these companies still have market capitalization above $2bn and negative earnings expectations, but they have fallen a lot over the past year combined with revenue growing such that their 12-month forward EV/Sales ratio has gone below 8x.
The 26 new stocks entering the basket are:
The table below shows the new updated bubble stocks basket and some key statistics. The bubble stocks basket now represents $687bn in market value down from $1,565bn a year ago highlighting the shareholder value destruction that has taken place in the part of the equity market. A year ago, the bubble stocks basket had a median 12-month forward EV/Sales ratio of 21.3x which has now declined to 14.6x.
Name | Mkt Cap (USD mn.) | 12M Fwd EPS | 12M Fwd EV/Sales | Diff to PT (%) | 5yr return (%) | YTD return (%) |
Rivian Automotive Inc | 54,874 | -4.97 | 14.8 | 118.1 | NA | -41.2 |
Lucid Group Inc | 45,160 | -1.02 | 17.7 | 61.6 | NA | -27.9 |
NU Holdings Ltd/Cayman Islands | 41,017 | -0.02 | 14.9 | 29.9 | NA | -5.1 |
Unity Software Inc | 31,483 | -0.13 | 19.7 | 47.6 | NA | -24.7 |
Cellnex Telecom SA | 30,482 | -0.08 | 10.6 | 67.5 | 277.2 | -23.3 |
Okta Inc | 29,623 | -0.45 | 16.5 | 43.5 | NA | -15.0 |
SenseTime Group Inc | 29,154 | -0.03 | 31.5 | 7.8 | NA | 23.3 |
MongoDB Inc | 27,998 | -0.90 | 23.8 | 32.8 | NA | -20.8 |
Seagen Inc | 25,598 | -0.49 | 10.3 | 29.5 | 132.7 | -9.5 |
Bill.com Holdings Inc | 24,468 | -0.48 | 31.9 | 32.2 | NA | -5.2 |
BeiGene Ltd | 23,748 | -11.04 | 13.7 | 80.2 | 486.6 | -22.0 |
Grab Holdings Ltd | 19,491 | -0.25 | 17.2 | 88.4 | NA | -26.9 |
Confluent Inc | 19,079 | -0.75 | 33.8 | 24.6 | NA | -5.4 |
Affirm Holdings Inc | 18,336 | -1.44 | 10.5 | 55.9 | NA | -35.1 |
Alnylam Pharmaceuticals Inc | 17,658 | -3.35 | 12.4 | 42.3 | 224.0 | -12.9 |
Qualtrics International Inc | 17,559 | 0.00 | 11.7 | 33.8 | NA | -13.1 |
Argenx SE | 15,084 | -19.10 | 67.2 | 30.4 | 1,494.6 | -19.8 |
Plug Power Inc | 12,657 | -0.24 | 9.4 | 98.5 | 1,761.0 | -22.2 |
Brookfield Renewable Corp | 12,373 | -0.17 | 13.1 | 24.7 | NA | -6.8 |
Wolfspeed Inc | 11,849 | -0.16 | 12.6 | 25.4 | 269.4 | -14.8 |
SentinelOne Inc | 11,568 | -0.68 | 28.2 | 48.9 | NA | -14.2 |
Robinhood Markets Inc | 11,559 | -1.07 | 9.3 | 59.1 | NA | -24.7 |
Samsara Inc | 11,031 | -0.31 | 21.9 | 35.1 | NA | -22.1 |
Gitlab Inc | 10,773 | -1.04 | 29.1 | 64.1 | NA | -14.5 |
Asana Inc | 10,246 | -0.98 | 19.9 | 58.9 | NA | -26.3 |
10X Genomics Inc | 10,118 | -0.24 | 13.6 | 109.8 | NA | -39.2 |
Avalara Inc | 9,383 | -0.19 | 10.2 | 68.3 | NA | -16.4 |
Monday.com Ltd | 9,141 | -2.44 | 17.9 | 78.1 | NA | -32.9 |
Biohaven Pharmaceutical Holding Co Ltd | 8,570 | -5.16 | 9.3 | 20.8 | NA | -5.1 |
Elastic NV | 8,497 | -0.45 | 8.2 | 73.6 | NA | -25.5 |
Procore Technologies Inc | 8,358 | -0.76 | 11.4 | 68.5 | NA | -20.8 |
Kingdee International Software Group Co Ltd | 8,770 | -0.04 | 9.7 | 57.5 | 529.5 | -18.0 |
Guidewire Software Inc | 8,042 | -0.24 | 9.2 | 36.1 | 76.9 | -15.0 |
Ginkgo Bioworks Holdings Inc | 8,028 | -0.15 | 21.7 | 118.5 | NA | -35.0 |
Smartsheet Inc | 7,952 | -0.25 | 10.3 | 46.7 | NA | -19.0 |
Novocure Ltd | 7,818 | -0.38 | 13.0 | 73.5 | 960.6 | 0.3 |
Shanghai Junshi Biosciences Co Ltd | 7,609 | -0.89 | 14.9 | 61.7 | NA | -19.4 |
Guardant Health Inc | 7,353 | -4.38 | 14.4 | 116.5 | NA | -27.7 |
Ascendis Pharma A/S | 7,021 | -8.05 | 65.0 | 53.5 | 423.9 | -8.2 |
Intellia Therapeutics Inc | 6,940 | -4.10 | 163.0 | 69.2 | 617.9 | -21.1 |
Aggregate / median | 686,470 | 14.6 | 56.7 | 455.3 | -19.6 |
Disclaimer
The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.
Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer)